Role of reactive oxygen species in neonatal pulmonary vascular disease

Stephen Wedgwood, Robin H Steinhorn

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Significance: Abnormal lung development in the perinatal period can result in severe neonatal complications, including persistent pulmonary hypertension (PH) of the newborn and bronchopulmonary dysplasia. Reactive oxygen species (ROS) play a substantive role in the development of PH associated with these diseases. ROS impair the normal pulmonary artery (PA) relaxation in response to vasodilators, and ROS are also implicated in pulmonary arterial remodeling, both of which can increase the severity of PH.

Recent Advances: PA ROS levels are elevated when endogenous ROS-generating enzymes are activated and/or when endogenous ROS scavengers are inactivated. Animal models have provided valuable insights into ROS generators and scavengers that are dysregulated in different forms of neonatal PH, thus identifying potential therapeutic targets.

Critical Issues: General antioxidant therapy has proved ineffective in reversing PH, suggesting that it is necessary to target specific signaling pathways for successful therapy.

Future Directions: Development of novel selective pharmacologic inhibitors along with nonantioxidant therapies may improve the treatment outcomes of patients with PH, while further investigation of the underlying mechanisms may enable earlier detection of the disease.

Original languageEnglish (US)
Pages (from-to)1926-1942
Number of pages17
JournalAntioxidants and Redox Signaling
Volume21
Issue number13
DOIs
StatePublished - Nov 1 2014

Fingerprint

Vascular Diseases
Lung Diseases
Reactive Oxygen Species
Pulmonary Hypertension
Pulmonary Artery
Persistent Fetal Circulation Syndrome
Bronchopulmonary Dysplasia
Therapeutics
Vasodilator Agents
Early Diagnosis
Animals
Animal Models
Antioxidants
Lung
Enzymes

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Physiology
  • Clinical Biochemistry

Cite this

Role of reactive oxygen species in neonatal pulmonary vascular disease. / Wedgwood, Stephen; Steinhorn, Robin H.

In: Antioxidants and Redox Signaling, Vol. 21, No. 13, 01.11.2014, p. 1926-1942.

Research output: Contribution to journalArticle

@article{2ed440c987324c41bd86b4de77844b99,
title = "Role of reactive oxygen species in neonatal pulmonary vascular disease",
abstract = "Significance: Abnormal lung development in the perinatal period can result in severe neonatal complications, including persistent pulmonary hypertension (PH) of the newborn and bronchopulmonary dysplasia. Reactive oxygen species (ROS) play a substantive role in the development of PH associated with these diseases. ROS impair the normal pulmonary artery (PA) relaxation in response to vasodilators, and ROS are also implicated in pulmonary arterial remodeling, both of which can increase the severity of PH.Recent Advances: PA ROS levels are elevated when endogenous ROS-generating enzymes are activated and/or when endogenous ROS scavengers are inactivated. Animal models have provided valuable insights into ROS generators and scavengers that are dysregulated in different forms of neonatal PH, thus identifying potential therapeutic targets.Critical Issues: General antioxidant therapy has proved ineffective in reversing PH, suggesting that it is necessary to target specific signaling pathways for successful therapy.Future Directions: Development of novel selective pharmacologic inhibitors along with nonantioxidant therapies may improve the treatment outcomes of patients with PH, while further investigation of the underlying mechanisms may enable earlier detection of the disease.",
author = "Stephen Wedgwood and Steinhorn, {Robin H}",
year = "2014",
month = "11",
day = "1",
doi = "10.1089/ars.2013.5785",
language = "English (US)",
volume = "21",
pages = "1926--1942",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "13",

}

TY - JOUR

T1 - Role of reactive oxygen species in neonatal pulmonary vascular disease

AU - Wedgwood, Stephen

AU - Steinhorn, Robin H

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Significance: Abnormal lung development in the perinatal period can result in severe neonatal complications, including persistent pulmonary hypertension (PH) of the newborn and bronchopulmonary dysplasia. Reactive oxygen species (ROS) play a substantive role in the development of PH associated with these diseases. ROS impair the normal pulmonary artery (PA) relaxation in response to vasodilators, and ROS are also implicated in pulmonary arterial remodeling, both of which can increase the severity of PH.Recent Advances: PA ROS levels are elevated when endogenous ROS-generating enzymes are activated and/or when endogenous ROS scavengers are inactivated. Animal models have provided valuable insights into ROS generators and scavengers that are dysregulated in different forms of neonatal PH, thus identifying potential therapeutic targets.Critical Issues: General antioxidant therapy has proved ineffective in reversing PH, suggesting that it is necessary to target specific signaling pathways for successful therapy.Future Directions: Development of novel selective pharmacologic inhibitors along with nonantioxidant therapies may improve the treatment outcomes of patients with PH, while further investigation of the underlying mechanisms may enable earlier detection of the disease.

AB - Significance: Abnormal lung development in the perinatal period can result in severe neonatal complications, including persistent pulmonary hypertension (PH) of the newborn and bronchopulmonary dysplasia. Reactive oxygen species (ROS) play a substantive role in the development of PH associated with these diseases. ROS impair the normal pulmonary artery (PA) relaxation in response to vasodilators, and ROS are also implicated in pulmonary arterial remodeling, both of which can increase the severity of PH.Recent Advances: PA ROS levels are elevated when endogenous ROS-generating enzymes are activated and/or when endogenous ROS scavengers are inactivated. Animal models have provided valuable insights into ROS generators and scavengers that are dysregulated in different forms of neonatal PH, thus identifying potential therapeutic targets.Critical Issues: General antioxidant therapy has proved ineffective in reversing PH, suggesting that it is necessary to target specific signaling pathways for successful therapy.Future Directions: Development of novel selective pharmacologic inhibitors along with nonantioxidant therapies may improve the treatment outcomes of patients with PH, while further investigation of the underlying mechanisms may enable earlier detection of the disease.

UR - http://www.scopus.com/inward/record.url?scp=84911875444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911875444&partnerID=8YFLogxK

U2 - 10.1089/ars.2013.5785

DO - 10.1089/ars.2013.5785

M3 - Article

VL - 21

SP - 1926

EP - 1942

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 13

ER -